Aptar Pharma presented a range of new Integrated Connected Inhalers during the scientific event Drug Delivery to the Lungs (DDL) held in Edinburgh Dec. 7-9, 2016.
The Integrated Connected Inhalers portfolio is composed of three platforms:
The event follows the announcement made in February 2016 about the Aptar Pharma and Propeller Health partnership to develop an Integrated cMDI.
The three Aptar Pharma cDevices are connected to the Propeller Health mobile application and services, making it a powerful adherence-promoter solution. It provides convenience and actionable feedbacks to patients and providers.
We invite you to watch a short video about connected devices from the recent DDL conference below.
For more information, please contact Chris Baron, Associate Director, Business Development.